Premium
COVID‐19 in a high‐risk dual heart and kidney transplant recipient
Author(s) -
Hsu Jeffrey J.,
Gaynor Pryce,
Kamath Megan,
Fan Ashley,
AlSaffar Farah,
Cruz Daniel,
Nsair Ali
Publication year - 2020
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.15936
Subject(s) - medicine , pandemic , covid-19 , infectious disease (medical specialty) , population , coronavirus , intensive care medicine , kidney transplantation , disease , immunology , transplantation , environmental health
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is rapidly infecting people worldwide, resulting in the infectious disease coronavirus disease 19 (COVID‐19) that has been declared a pandemic. Much remains unknown about COVID‐19, including its effects on solid organ transplant (SOT) recipients. Given their immunosuppressed state, SOT recipients are presumed to be at high risk of complications with viral infections such as SARS‐CoV‐2. Limited case reports in single SOT recipients, however, have not suggested a particularly severe course in this population. In this report, we present a dual‐organ (heart/kidney) transplant recipient who was found to have COVID‐19 and, despite the presence of a number of risk factors for poor outcomes, had a relatively mild clinical course.